Primary Care Perspectives on HCV and HIV Screening and Treatment in the Primary Care Setting
COVID-19 is compounding drug and alcohol problems across Wisconsin, with suspected opioid overdoses increasing by [preliminary] 117 percent since the start of the pandemic compared to the same time in 2019. With the advancements of HCV treatment and Medicaid restrictions recently being lifted, primary care prescribers can more effectively treat people with HCV.
This activity is designed for physicians, pharmacists, and nurses in clinics caring for and providing treatment to patience with or at risk of contracting HCV.
By participating in this activity learners will be able to:
- Explain the impact of HCV and HIV in underserved and marginalized communities in Wisconsin.
- Describe how stigma plays a role in successful prevention, care and treatment of communicable diseases such as HCV and HIV.
- Summarize the role primary care teams have in screening for and treating HCV and HIV.
- Identify existing learning resources and clinical guidelines.
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made available in the activity handout materials.
|In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and Midwest AIDS Training + Education Center. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.|
CREDIT DESIGNATION STATEMENTS
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
A maximum of 1 hour of knowledge-based CE credit can be earned by successfully completing this live activity. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance, will be provided to NABP within 60 days after the activity completion.
2021 Universal Activity Number (UAN) JA0000358-9999-21-082-L01-P
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
- 1.00 ACPE Contact Hours - Pharmacist
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™